Reframe Cancer has appointed professor Ben Kelly as chief operating officer.
He joins Reframe Cancer from Nuffield Health, where he spent 10 years within their senior leadership team.
As data director, Kelly (pictured) embedded data and evidence first approaches across Nuffield Health and is an authority on the design and delivery of care pathways with a particular focus on primary and secondary prevention.
He has worked within healthcare and clinical research for the entirety of his career both clinically within cardiology as well as strategically across governmental groups and the independent sector.
He has also led several functions including clinical research and innovation, data science, clinical outcomes and impact and operational excellence.
Kelly said: “I’m incredibly excited to join an organisation with such a strong purpose and focus.
“The opportunity to improve the quality of life of cancer patients is an honour and is something I am 100% motivated by and committed to.
“What the cancer nurse specialists and support managers achieve for patients at Reframe is amazing.
“I aim to do all I can to support these teams and positively contribute to the growth of this incredible organisation whilst keeping the patient front and centre.”
Mark Stephenson, CEO at Reframe Cancer, added: “We’re naturally thrilled that Professor Ben Kelly has joined Reframe Cancer as chief operating officer.
“His experience and clinical data expertise will facilitate Reframe Cancer in supporting even more patients as well as delivering industry leading outcomes.
“Ben is another senior hire that reflects not just Reframe’s growth and strength, but its commitment to delivering the highest level of clinical excellence for cancer patients.”
